GlaxoSmithKline (GB:GSK) has released an update.
GlaxoSmithKline (GSK), a leading global biopharma company, has announced a change in its registered office address, relocating to 79 New Oxford Street, London, with immediate effect. The move symbolizes GSK’s continued evolution and commitment to advancing the fight against diseases through innovative science and technology. Stakeholders and interested parties are directed to update their records to reflect GSK’s new address for any future correspondence.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.
